期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 61, 期 3, 页码 1031-1044出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.7b01474
关键词
-
资金
- Sterix Ltd., a member of the Ipsen Group
- Swiss National Science Foundation [31003A_166608]
Quinazolinone-based anticancer agents were designed, decorated with functional groups from a 2-methoxyestradiol-based microtubule disruptor series, incorporating the aryl sulfamate motif of steroid sulfatase (STS) inhibitors. The steroidal AB-ring system was mimicked, favoring conformations with an N-2 substituent Occupying D-ring space. Evaluation against breast and prostate tumor cell lines identified 7b with DU-145 antiproliferative activity (GI(50) 300 nM). A preliminary structure-activity relationship afforded compounds (e.g., 7j GI(50) 50 nM) with activity exceeding that of the parent. Both 7b and 7j inhibit tubulin assembly in vitro and colchicine binding, and 7j was successfully co-crystallized with the alpha beta-tubulin heterodimer as the first of its class, its sulfamate group interacting positively at the colchicine binding site. Microtubule destabilization by 7j is likely achieved by preventing the curved-to-straight conformational transition in alpha beta-tubulin. Quinazolinone sulfamates surprisingly showed weak STS inhibition. Preliminary in vivo studies in a multiple myeloma xenograft model for 7b showed oral activity, confirming the promise of this template.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据